Pre-surgical psychiatric evaluation did not appear all at once. It grew, surgery by surgery, as outcome data made one pattern clear: a patient's mental health before the operating room predicts how the procedure performs afterward. What started as an informal conversation between a surgeon and a colleague in psychiatry has matured into a structured, documentable step that protects the patient, the surgeon, and the procedure itself.
The earliest pre-surgical psychiatric workups appeared in organ transplant programs in the 1970s and 1980s, where the cost of a graft and the demand on the recipient made it obvious that mental health and adherence belonged in the candidacy decision. Bariatric surgery adopted the practice in the 1990s and 2000s as long-term outcomes data showed that weight regain, post-op alcohol misuse, and program drop-off were not random — they tracked closely with depression, untreated anxiety, eating-disorder symptoms, and unrealistic expectations. By the time spinal cord stimulators, deep brain stimulation, vagus nerve stimulation, and large-scale cosmetic procedures became routine, the model was already established: a brief, standardized, documented assessment before the procedure.
Surgeons did not begin requiring clearance because regulators told them to. They began requiring it because they were tired of the same post-op surprises — the bariatric patient who could not maintain the dietary protocol, the spinal cord stimulator recipient whose pain catastrophizing predicted poor device response, the transplant candidate whose untreated substance use derailed an otherwise excellent surgical outcome. Clearance gives the surgical team a structured second opinion on three things the operative consent cannot capture alone: whether the patient understands the procedure, whether they can engage with the recovery, and whether any treatable psychiatric condition should be optimized first.
The published literature has converged on a few durable findings — enough that most insurers and most surgical societies now treat a documented psychiatric evaluation as part of the standard preoperative workup for the procedures AlviPsych covers.
Across multiple specialties, untreated depression and active substance use disorders are associated with worse surgical outcomes: slower wound healing, higher post-op pain reports, more readmissions, lower adherence to post-op protocols, and reduced long-term satisfaction. In bariatric cohorts, depression and binge-eating symptoms at baseline predict weight regain at two and five years. In transplant cohorts, active substance use predicts graft loss. In pain-implant cohorts, depression and pain catastrophizing predict reduced device benefit. None of these findings argue that a patient with depression cannot have surgery — they argue that the surgical team should know about it.
The second line of evidence is procedural rather than diagnostic. Most of the surgeries that require clearance ask a great deal of the patient afterward: dietary protocols, device-programming visits, immunosuppressant regimens, smoking cessation, lifelong follow-up. A psychiatric evaluation documents that the patient understands what they are agreeing to, has the cognitive capacity to engage with the recovery, and has realistic expectations about the result. That documentation matters to the surgeon, the insurer, and any later medico-legal review.
Bariatric is where the evidence base is thickest. National accreditation programs effectively require a pre-operative psychological assessment, and major payers expect it inside the prior-authorization packet. The most reliable predictors are not personality traits or single diagnoses but functional markers — eating patterns under stress, adherence to the supervised diet, understanding of the post-op behavior change, and stability of mood and substance use over the months leading up to surgery. That is exactly what a structured screener set (PHQ-9, GAD-7, AUDIT-C, DAST-10, BES) plus a brief clinical interview is designed to capture.
For DBS, VNS, spinal cord stimulators, and transplant candidacy, the screener mix shifts but the logic is identical: capacity to consent, realistic expectation of benefit, and any treatable psychiatric condition optimized before the procedure. Clearance is not pass/fail. It is a structured way to give the surgeon the information that the surgical consult cannot easily generate in fifteen minutes.
Mechanick JI, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures — 2019 update. Surg Obes Relat Dis. 2020.
Maldonado JR, et al. The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT). Psychosomatics. 2012;53(2):123–132.
Sweis BM, et al. Psychological screening before spinal cord stimulator implantation: predictive validity and outcomes. Neuromodulation. 2017.
Sarwer DB, Heinberg LJ. A review of the psychosocial aspects of clinically severe obesity and bariatric surgery. Am Psychol. 2020.
